The patient presented with a large right renal mass who elected for right radical nephrectomy with possible inferior vena cava.
In this educational video, physicians from the Urology Department in the University of Kansas Health System demonstrate how to assemble a Thompson Retractor for midline transabdominal retroperitoneal surgery in a 68-year-old patient who presented with a large right renal mass and elected to receive right radical nephrectomy with possible inferior vena cava resection.
Transcript
In this video, we will discuss the importance of knowing how to properly assemble a Thompson surgical retractor before entering the operating room. As medical students and surgical residents, it's crucial to have a strong understanding of all surgical instruments, including retractors. The Thompson retractor is commonly used in various surgical procedures and is an essential tool for exposure of tissues.
A well-assembled retractor ensures that it functions as intended and minimizes the risk of injury to the patient. Additionally, perhaps underappreciated, being able to quickly and efficiently assemble a Thompson retractor can save valuable time during a surgery and improve overall surgical efficiency.
We will provide step-by-step instructions on how to properly assemble a Thompson retractor, including the placement of blades and handles. By the end of this video, it is our hope that you have a better understanding of the importance of knowing how to assemble a Thompson retractor and the impact it has on patient safety and surgical outcomes. So, let's get started and learn how to master this essential surgical tool.
Remember, patient safety should always be the top priority in the operating room and knowing how to properly use and assemble surgical instruments like the Thompson retractor is an important aspect of ensuring safe and successful surgeries.
Adding nivolumab to low-dose tivozanib does not improve PFS in renal cell carcinoma
July 19th 2024"While the addition of an ICI to low dose FOTIVDA did not improve PFS outcomes after prior ICI, we consider the control arm data an important, evidence-based and clinically meaningful contribution to the oncology community treating relapsed or refractory advanced RCC following front-line ICI combinations," says Michael P. Bailey.
Live bacterial supplementation may improve TKI-based treatment efficacy in kidney cancer
June 30th 2024CBM588 could be exciting in cancer treatment because of its potential to enhance the efficacy of immune checkpoint inhibitor-based treatment, improve patient outcomes, and modulate the gut microbiota in beneficial ways,” says Sumanta Pal, MD.
Pembrolizumab/lenvatinib labels updated to include KEYNOTE-B61 data in non-ccRCC
June 28th 2024"The addition of efficacy data from the KEYNOTE-B61 trial reinforces the important role of KEYTRUDA plus LENVIMA as a frontline treatment option for adult patients with advanced RCC regardless of histology," says Takashi Owa, PhD.